HSTM
HealthStream, Inc. Healthcare - Health Information Services Investor Relations →
HealthStream, Inc. (HSTM) closed at $25.64 as of 2026-06-19, trading 0.7% below its 200-week moving average of $25.83. This places HSTM in the below line zone. The stock is currently moving closer to the line, down from 1.2% last week. With a 14-week RSI of 70, HSTM is in overbought territory.
Trading volume is running at 0.9x of its 14-week average, which is in the normal range. The balance between buying and selling volume (1.32 ratio) is neutral — neither side is clearly dominating.
Over the past 1318 weeks of data, HSTM has crossed below its 200-week moving average 25 times. On average, these episodes lasted 20 weeks. Historically, investors who bought HSTM at the start of these episodes saw an average one-year return of +15.4%.
With a market cap of $749 million, HSTM is a small-cap stock. The company generates a free cash flow yield of 6.7%, which is healthy. Return on equity stands at 5.6%. The stock trades at 2.1x book value.
Management has been repurchasing shares, with a 3.3% reduction over three years. This stock also meets the Yartseva multibagger criteria as a small-cap with strong free cash flow yield and reasonable book value.
Over the past 25.3 years, a hypothetical investment of $100 in HSTM would have grown to $2172, compared to $1011 for the S&P 500. That represents an annualized return of 12.9% vs 9.6% for the index — confirming HSTM as a market-beating investment and the kind of quality company where buying during 200-week moving average touches has historically been rewarded.
Free cash flow has been growing at a 6.1% compound annual rate, with 4 consecutive years of positive cash generation. A business generating more cash every year while trading below its 200-week moving average is exactly the kind of disconnect value investors look for.
Business Health
Annual financials — how the underlying business has performed over the past several years.
Cash Flow Free cash flow & net income ($M)
Revenue Annual revenue ($M) — business growth proxy
Total Debt Balance sheet debt ($M)
ROIC Return on invested capital (%)
FCF Yield Free cash flow / market cap (%) — Yartseva signal
Gross Margin Pricing power & competitive moat (%)
Shares Outstanding Buybacks vs dilution (millions)
Growth of $100: HSTM vs S&P 500
Monthly data normalized to $100 at start. Vertical dashed lines mark 200-week MA touches.
What Happens After HSTM Crosses Below the Line?
Across 25 historical episodes, buying HSTM when it crossed below its 200-week moving average produced an average return of +12.0% after 12 months (median +7.0%), compared to +9.3% for the S&P 500 over the same periods. 77% of those episodes were profitable after one year. After 24 months, the average return was +16.8% vs +20.3% for the index.
Each line shows $100 invested at the moment HSTM crossed below its 200-week MA. Bold blue = stock average. Gray dashed = S&P 500 average over same periods.
Bean Score Experimental
The Bean Score measures how far a stock's free cash flow yield has deviated from its own quarterly baseline, normalized by the stock's historical behavior. Between earnings dates, FCF is constant — so the score is purely a function of stock price. The levels below show at what prices HSTM would reach each dislocation threshold.
Dislocation Price Levels
Prices where HSTM's Bean Score would hit each σ threshold. Valid until next earnings report: 2026-08-03.
| Level | σ | Price | Signal |
|---|---|---|---|
| Deep Value | +2σ | $17.05 | Unusually cheap — potential buy zone |
| Value | +1σ | $18.55 | Cheap vs. own history |
| Fair Value | +0σ | $20.35 | Historical mean behavior |
| Expensive | -1σ | $22.53 | Expensive vs. own history |
| Deep Expensive | -2σ | $25.23 | Unusually expensive — potential trim zone |
Quarterly FCF & Yield Trailing twelve-month free cash flow and yield at each quarter end
Signal Accuracy Collecting Data
The Bean Score system is accumulating weekly data to validate signal accuracy. After 13+ weeks of history, this section will display win rates and average returns for each σ threshold crossing — answering the question: "When this score says cheap or expensive, does the price subsequently move in the expected direction?"
Theoretical framework — not backtested or forward-tested. The Bean Score uses trailing twelve-month free cash flow yield as a dislocation identifier. It measures whether the market has pushed a stock's yield unusually far from its own baseline behavior. These levels are reference points for identifying potential swing trade opportunities, not buy/sell signals. FCF values update quarterly with earnings; between reports, all movement is price-driven.
Dislocation Scores Experimental
Each score measures deviation from HSTM's own historical baseline — the same idea as the Bean Score, applied to different fundamentals. Positive means cheaper or more dislocated than this stock's norm. Scores marked σ are normalized by the stock's own variability; pp values are simple deltas from its recent baseline.
Theoretical framework — not backtested. These scores describe how unusual today's readings are for this specific company. They are starting points for research, not buy or sell signals. Annual-statement scores (buyback, accruals, FCF vs history) rest on only ~4 yearly data points and are deltas, not sigmas.
Historical Touches
HSTM has crossed below its 200-week MA 25 times with an average 1-year return of +15.4% after recovery.
| Crossed Below | Recovered | Weeks | Max Depth | 1-Year Return | Return Since Touch |
|---|---|---|---|---|---|
| Mar 2001 | Jun 2003 | 115 | 68.5% | -20.0% | +1509.0% |
| Sep 2004 | Sep 2004 | 1 | 5.3% | +116.5% | +1555.6% |
| Oct 2005 | Oct 2005 | 2 | 5.0% | +88.3% | +1224.5% |
| Nov 2005 | Nov 2005 | 3 | 4.5% | +56.9% | +1157.0% |
| Dec 2005 | Dec 2005 | 2 | 4.6% | +97.6% | +1193.0% |
| Jul 2007 | Oct 2007 | 9 | 13.8% | -20.3% | +802.1% |
| Nov 2007 | Nov 2007 | 1 | 4.5% | -18.8% | +829.9% |
| Jan 2008 | Jul 2009 | 80 | 45.8% | -24.4% | +784.4% |
| Aug 2015 | Jul 2016 | 47 | 32.2% | -6.2% | +5.5% |
| Jul 2016 | Sep 2016 | 9 | 8.6% | +0.7% | +5.1% |
| Oct 2016 | Oct 2016 | 1 | 1.2% | -8.4% | +3.6% |
| Oct 2016 | Apr 2017 | 25 | 17.0% | +6.8% | +23.1% |
| Jun 2017 | Mar 2018 | 36 | 13.5% | +8.2% | +3.2% |
| Apr 2018 | Apr 2018 | 1 | 0.7% | +9.6% | +8.6% |
| Nov 2018 | Nov 2018 | 2 | 2.7% | +12.1% | +7.3% |
| Dec 2018 | Jan 2019 | 3 | 4.9% | +19.8% | +11.9% |
| Feb 2020 | Jan 2021 | 46 | 26.8% | -4.2% | +7.1% |
| Jan 2021 | May 2021 | 14 | 10.7% | +5.0% | +11.9% |
| Nov 2021 | Dec 2021 | 5 | 6.9% | -0.9% | +3.3% |
| Jan 2022 | Nov 2022 | 43 | 24.4% | -3.5% | +3.1% |
| Jan 2023 | Feb 2023 | 6 | 3.4% | +9.1% | +8.2% |
| May 2023 | Oct 2023 | 25 | 12.0% | +14.2% | +9.5% |
| Jul 2025 | Aug 2025 | 1 | 0.1% | N/A | +0.5% |
| Oct 2025 | Oct 2025 | 1 | 0.5% | N/A | +0.6% |
| Oct 2025 | Ongoing | 34+ | 22.9% | Ongoing | +4.7% |
| Average | 20 | — | +15.4% | — |
Frequently Asked Questions
Is HSTM below its 200-week moving average?
Yes. As of 2026-06-19, HealthStream, Inc. (HSTM) is trading 0.7% below its 200-week moving average of $25.83. The current price is $25.64.
What is HSTM's 200-week moving average price?
HealthStream, Inc.'s 200-week moving average is $25.83 as of 2026-06-19. This is the average weekly closing price over roughly the last 4 years, and it acts as a long-term trend line. When a stock drops below this level, it can signal that the price has fallen far enough from the long-term trend to attract value-oriented investors.
What happens when HSTM drops below its 200-week moving average?
HSTM has crossed below its 200-week moving average 25 times in our data. On average, buying at that moment produced a one-year return of +15.4%. These dips have historically been decent entry points. These episodes lasted 20 weeks on average.
Is HSTM a good value right now?
Here's what our data says about HSTM as of 2026-06-19: The stock is below its 200-week moving average, which is the starting point for our analysis. The 14-week RSI is 70 (overbought). Free cash flow yield is 6.7%. Return on equity is 5.6%. Price-to-book is 2.1x. This is not a buy or sell recommendation — always do your own research.
How does HSTM compare to the S&P 500?
Over the past 25.3 years, $100 invested in HSTM would have grown to $2172, compared to $1011 for the S&P 500. That's 12.9% annualized vs 9.6% for the index. HSTM has outperformed the broader market over this period.
Does HSTM pay a dividend?
Yes. HealthStream, Inc. currently pays a dividend yield of 51.00%.
Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.
Data as of week of 2026-06-19